Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Retained Earnings Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Retained Earnings
-$3.6B
CAGR 3-Years
-12%
CAGR 5-Years
-17%
CAGR 10-Years
-7%
Johnson & Johnson
NYSE:JNJ
Retained Earnings
$155.2B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Retained Earnings
$16.1B
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-7%
Pfizer Inc
NYSE:PFE
Retained Earnings
$116.6B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Retained Earnings
$61.4B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Retained Earnings
$13.6B
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
-2%

See Also

What is Nektar Therapeutics's Retained Earnings?
Retained Earnings
-3.6B USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Retained Earnings amounts to -3.6B USD.

What is Nektar Therapeutics's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-7%

Over the last year, the Retained Earnings growth was -5%. The average annual Retained Earnings growth rates for Nektar Therapeutics have been -12% over the past three years , -17% over the past five years , and -7% over the past ten years .

Back to Top